Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BIIB
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Biogen Inc (BIIB) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Biogen (BIIB) trades at $224.92, up 0.59% today, with a neutral technical signal and bullish moving averages. The company has beaten EPS estimates for three consecutive quarters, with a P/E of 39.59 and a net income margin of 8.32%. Recent news highlights positive Phase 2 data for its lupus drug litifilimab and expansion into immunology and kidney disease. Cash flow from operations was $2.20 billion in 2025, and the balance sheet shows a debt-to-asset ratio of 22.44%.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $245.88 price target and 63% buy ratings. Key opportunities include pipeline advancements in neuroscience and immunology, but risks involve competitive pressures, regulatory hurdles, and projected net income decline to $835 million in 2026. The stock's valuation remains elevated, requiring execution on growth initiatives to justify further upside.
Read full analysis

Key Stats

  • Market Cap
    $32.93B
  • Volume
    1,008,092
  • Sector
    Health
  • 52W High
    $228.69
  • 52W Low
    $142.26
  • Typical Hold Time
    111 Days
  • Enterprise Value
    $40.00B
  • Div Yield
    -
  • Trading Activity
    49% Sell | 51% Buy
$222
52W Low: $142.26
16 Oct 2025
52W High: $228.69
28 Sep 2026

Track Biogen Inc (BIIB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Biogen Inc has traded between a low of $142.26 and a high of $228.69, highlighting its annual price range. Buy and sell Biogen Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Most Recent News

Content is generated by Aura AI

SCWorx shares resume trading on Nasdaq after reversing delisting with improved financials.

SCWorx Corp. has resumed trading on the Nasdaq Capital Market on October 7, 2026, after a suspension that began in April. The company successfully reversed a delisting decision by regaining compliance with Nasdaq's minimum bid price and publicly held...

Market News
24 minutes ago
Alex Lavoie
Bullish
news icon
SCWorx shares resume trading on Nasdaq after reversing delisting with improved financials.

Star Bulk Carriers COO buys 10,000 shares at $28.27, sparking buy interest in SBLK.

Star Bulk Carriers' Chief Operating Officer, Reskos, purchased 10,000 shares at $28.27 each. This insider buying signals confidence in the company's prospects and may encourage investors to consider buying SBLK stock. The move could indicate positive...

Market News
1 hour ago
Brendan Coffey
Bullish
news icon
Star Bulk Carriers COO buys 10,000 shares at $28.27, sparking buy interest in SBLK.

AeroVironment stock drops 43% amid accounting errors and sector-wide defense stock declines.

AeroVironment's stock has fallen 43% this year following a disclosed $89 million goodwill accounting error and a resulting securities class action lawsuit. However, similar declines in peers like Kratos and Red Cat suggest the drop is partly due to a...

Market News
4 hours ago
24/7 Wall Street
Bearish
news icon
AeroVironment stock drops 43% amid accounting errors and sector-wide defense stock declines.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $32.93B
  • Volume
    1,008,092
  • Sector
    Health
  • 52W High
    $228.69
  • 52W Low
    $142.26
  • Typical Hold Time
    111 Days
  • Enterprise Value
    $40.00B
  • Div Yield
    -
  • Trading Activity
    49% Sell | 51% Buy
$222
52W Low: $142.26
16 Oct 2025
52W High: $228.69
28 Sep 2026

Track Biogen Inc (BIIB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Biogen Inc has traded between a low of $142.26 and a high of $228.69, highlighting its annual price range. Buy and sell Biogen Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!